Eukaryotic cells employ checkpoint pathways to coordinate DNA replication, DNA repair and cell cycle progression after DNA damage or replication stress[@b1][@b2][@b3][@b4][@b5]. Mec1 and Rad53, the homologues of mammalian ATR and Chk2, respectively, are the central protein kinases of the S phase checkpoint in the budding yeast *Saccharomyces cerevisiae*. Their activation triggers a global checkpoint response regulating different processes, including transcriptional induction of DNA damage response genes, inhibition of late replication origin firing, stabilization of stalled DNA replication forks and inhibition of cell cycle progression[@b6][@b7]. Of these, replication fork stabilization appears to be most important to prevent cell lethality after genotoxic stress[@b8][@b9][@b10][@b11]. Previous work indicated that the primary role of Rad53 in fork stabilization after DNA damage is to prevent Exo1-dependent replication fork breakdown[@b11][@b12]. Deletion of *EXO1* suppresses replication fork catastrophe in *rad53* mutants treated with the alkylating agent methyl methanosulfonate (MMS) and reduces the sensitivity of *rad53* mutants to a wide variety of DNA damaging agents, including UV and ionising radiation[@b11]. Strikingly, however, deletion of *EXO1* is completely ineffective in suppressing the sensitivity of *rad53* mutants to the ribonucleotide reductase (RNR) inhibitor hydroxyurea (HU)[@b11], despite the fact that *EXO1* deletion suppresses the degradation of replication forks in HU[@b12]. This argues for the existence of an Exo1-independent mechanism, which is regulated by Rad53 and required for cell viability after HU arrest. This mechanism might involve direct effects on replisome components[@b12][@b13][@b14] or some other function of Rad53.

Previous work has indicated that this additional mechanism is unlikely to be the well-documented role of checkpoints in inhibiting mitosis, since the microtubule inhibitor nocodazole, which prevents mitotic entry, does not markedly rescue the lethality of *rad53*Δ or *rad53*Δ*exo1*Δ mutant strains after HU treatment[@b11]. Rad53 inhibits late origin firing via Sld3 and Dbf4 phosphorylation; however, this inhibition of late origin firing makes at best a small contribution to cell viability in the presence of HU[@b15][@b16] and is therefore also unlikely to represent this other function. Rad53 is a critical regulator of transcriptional responses after DNA damage and replicative stress[@b17][@b18]. Although inhibiting protein synthesis does not seem to compromise viability or recovery after fork stalling in wild-type cells[@b8][@b19], it is required to restore normal rates of DNA synthesis after replication blocks[@b8], indicating that new protein synthesis and, perhaps, checkpoint-dependent transcriptional induction may play some role in replication resumption. Rad53 regulates transcription by activating the downstream Dun1 kinase, which phosphorylates and inactivates the transcriptional repressor Crt1[@b20]. This leads to the induction of a large number of damage-inducible genes, including those encoding the RNR subunits Rnr2, Rnr3 and Rnr4[@b21][@b22]. In *S. cerevisiae*, RNR is a tetrameric enzyme composed of two dimeric subunits, a large R1 and a small R2. The RNR large subunit contains the catalytic site, and it is encoded by the *RNR1* and *RNR3* genes[@b23][@b24]. The small subunit is a heterodimer formed by the products of the genes *RNR2* and *RNR4*[@b25][@b26]. Recent reports indicate that *RNR1* transcription is activated in response to genotoxic stress via Ixr1, in a Mec1-- Rad53-dependent but Dun1-independent manner[@b27]. Rad53 and Dun1 also regulate RNR activity post-transcriptionally by phosphorylation of small protein regulators of RNR activity (Sml1)[@b28][@b29] and localization (Dif1)[@b30][@b31]. It has been shown too that Rnr2 and Rnr4 redistribute from the nucleus to the cytoplasm after DNA damage or replicative stress[@b32]. Rnr2-Rnr4 nuclear localization is controlled by the inhibitor Dif1, whose phosphorylation and degradation in response to DNA damage promotes Rnr2-Rnr4 cytoplasmic localization[@b30][@b31]. Similarly, dynamic changes in RNR localization have also been reported in fission yeast[@b33], although it is unclear whether nuclear translocation is an RNR-regulatory mechanism conserved in mammalian cells[@b34][@b35][@b36][@b37].

In this study, we sought to test the possibility that the Exo1-independent mechanism described above involves RNR regulation. Our work indicates that Rad53 has a role in promoting fork restart by inducing the expression of *RNR* genes and by regulating RNR subcellular localization after HU-induced replicative stress.

Results
=======

*EXO1* deletion improves replication restart in *rad53* mutants after replicative stress
----------------------------------------------------------------------------------------

*EXO1* deletion was able to suppress fork collapse but not the lethality of *rad53*Δ mutants treated with HU ([Fig. 1a](#f1){ref-type="fig"}[@b11]). This led us to investigate whether Exo1 could influence replication restart after HU arrest. We first compared the replication pattern of *RAD53^+^*, *rad53*Δ and *rad53*Δ*exo1*Δ cells during S phase in the presence of HU and after release from the block induced by this drug. Cells were synchronized in G1 and released into S-phase in the presence of 0.2 M HU ([Fig. 1b](#f1){ref-type="fig"}). In the three strains, the cells entered normally into S-phase, as indicated by the estimation of the budding index in all cases (\>95% budded cells after 120 min in HU, not shown), but the rate of replication was significantly reduced due to the depletion of dNTP levels caused by HU, and the cells arrested with a DNA content close to 1C. Flow cytometry shows that, after HU removal, *RAD53^+^* cells efficiently resumed and completed replication ([Fig. 1b](#f1){ref-type="fig"}). In agreement with previous results[@b38], *rad53*Δ cells showed a clear defect in replication resumption, and thus in these cells the DNA content did not reach the 2C peak, even 120 min after HU removal. Although *rad53*Δ*exo1*Δ cells were also defective in replication restart, the DNA peaks were clearly broader than in the *rad53*Δ mutant, suggesting that some replication might be occurring after HU-release in the absence of Exo1.

To test whether the increase in DNA-content observed in *rad53*Δ*exo1*Δ cells after release from a HU-block reflected replication fork recovery, we used density transfer ([Fig. 1c](#f1){ref-type="fig"}), a technique that allows the study of on-going DNA synthesis across a specific genomic region[@b8][@b10][@b39]. Using this approach, we examined the progression of replication forks along a previously characterized replicon on chromosome VI[@b10], from the *ARS607* origin (fragment 1) to a position located 20 kb away (fragment 3) ([Fig. 1c](#f1){ref-type="fig"}). Cells were pre-grown in the presence of heavy isotopes (^13^C glucose, ^15^N ammonium sulphate) during seven generations, to generate Heavy-Heavy (HH) DNA. After G1 arrest with the α-factor mating pheromone, the cells were released into fresh medium containing HU in the presence of light isotopes (^12^C glucose, ^14^N ammonium sulphate) for 90 min, and finally cells were released into fresh medium for 120 min ([Fig. 1c](#f1){ref-type="fig"} and [Supplementary Fig. S1](#s1){ref-type="supplementary-material"}). Semi-conservative DNA replication generates products of the hybrid, Heavy-Light (HL) density. HH-DNA (unreplicated) was separated from HL-DNA (replicated) by ultracentrifugation of DNA in CsCl gradients after restriction endonuclease digestion. The localization of restriction fragments in fractions from the gradient was performed by hybridization with specific probes.

In *RAD53^+^* cells, fragment 1 was partially replicated in HU-arrested cells, as seen by the appearance of some HL DNA, while fragment 3 remained unreplicated (HH DNA) ([Fig. 1c](#f1){ref-type="fig"}). This indicated that the *ARS607* origin had fired and that replication forks stalled within fragment 1 as a consequence of the HU treatment. After release from HU arrest (120 min), both fragments 1 and 3 were fully replicated (HL DNA), indicating that the majority of replication forks resumed DNA synthesis after HU removal. In *rad53*Δ cells, considerably less replication of fragment 1 was detected during HU treatment ([Fig. 1c, d](#f1){ref-type="fig"}), consistent with previous results obtained with *rad53* and *mec1* checkpoint mutants in the presence of HU[@b40][@b41]. Moreover, in contrast to wild type cells, *rad53*Δ cells showed little replication of fragment 3 (25%) and only partial replication of fragment 1 (68%) after release (120 min) from the HU arrest ([Fig. 1c, d](#f1){ref-type="fig"}). This result indicates that most DNA replication forks were unable to restart in the *rad53*Δ strain after fork stalling. Remarkably, deletion of *EXO1* in the *rad53*Δ background increased the amount of replication of fragment 3 after release from HU arrest from 25% to 41% ([Fig. 1c, d](#f1){ref-type="fig"}), indicating more efficient replication restart in this strain than in the *rad53*Δ mutant. It is worth noting that the small proportion of replication forks that resume replication after release from the HU block in both *rad53*Δ and *rad53*Δ*exo1*Δ mutants were previously undetected by other techniques such as two dimensional electrophoresis or alkaline agarose gels of BrdU-labelled DNA[@b9][@b11][@b12], indicating the usefulness of density transfer in quantitative analysis of DNA replication. Taken together, these experiments confirm that Rad53 is critical for resumption of replication after HU arrest and show that the Exo1 pathway makes a small but detectable contribution to fork recovery. Nevertheless, although *EXO1* deletion improves fork restart in cells lacking Rad53, it is not sufficient for these mutant cells to fully resume DNA replication after replicative stress, and therefore other players must be involved in this process.

Co-induction of large and small RNR subunits and *EXO1* deletion contribute to suppress the lethality of *rad53* mutants treated with HU
----------------------------------------------------------------------------------------------------------------------------------------

The inability of *EXO1* deletion to suppress the sensitivity of *rad53* cells to HU as well as to abolish the replication resumption defect of these checkpoint mutant cells after treatment with this drug ([Fig. 1](#f1){ref-type="fig"}), suggests that Rad53 might allow cells to cope with this kind of replicative stress through an Exo1-independent mechanism. The results above pointed out that only some replication forks were able to restart after HU release in cells lacking Rad53 ([Fig. 1c](#f1){ref-type="fig"}), even when fork degradation was prevented in the absence of Exo1, arguing that a critical factor for replication fork restart might be limiting. Rad53 has a crucial role in regulating RNR, which is the target of HU[@b42], and therefore, we reasoned that this enzymatic complex could be a strong candidate for such a potential limiting factor. Thus, we investigated the contribution of checkpoint-dependent *RNR* expression to cell viability and DNA replication resumption after HU arrest.

It is known that expression of the *RNR1* gene from the inducible *GAL1-10* promoter increases dNTP levels[@b43]. Therefore, we first induced the expression of *RNR1* in *rad53*Δ mutant cells using a *pGAL-RNR1* construct ([Supplementary Fig. S2a](#s1){ref-type="supplementary-material"}) and tested the sensitivity of this strain to HU. [Figure 2a](#f2){ref-type="fig"} shows that *RNR1*-overexpression did not rescue the lethality of *rad53* mutant cells to HU. Similar results were obtained by expression of the other RNR large subunit, encoded by the *RNR3* gene ([Supplementary Fig. S2a, b](#s1){ref-type="supplementary-material"}), which is specifically induced after genotoxic stress[@b23][@b24]. These results were in agreement with a previous report showing that overexpression of *RNR1* or *RNR3* allows *mec1*Δ or *rad53*Δ cells to survive but it does not suppress their DNA damage sensitivities[@b33]. In addition, we also found that the individual overexpression of *RNR2* or *RNR4* did not rescue the viability of *rad53*Δ cells treated with HU either ([Supplementary Fig. S2a, b](#s1){ref-type="supplementary-material"}). On the contrary, the simultaneous expression of *RNR2* and *RNR4*, as well as the co-expression of large and small subunits of RNR (*RNR3-RNR2-RNR4 or RNR1-RNR2-RNR4*) significantly increased the resistance of *rad53*Δ cells to HU ([Fig. 2b](#f2){ref-type="fig"}). This occurred despite the fact that overexpression of several RNR subunits has a toxic effect that causes greatly reduced growth of the *rad53*Δ strain ([Fig. 2c](#f2){ref-type="fig"}, YPGal). Interestingly, all the strains that were able to suppress *rad53* HU-sensitivity expressed both *RNR2* and *RNR4* ([Fig. 2b](#f2){ref-type="fig"} and [Supplementary Fig. S2c, d](#s1){ref-type="supplementary-material"}), strongly suggesting that expression of the RNR small subunit is essential for survival after HU-induced replicative stress in the absence of Rad53. Nevertheless, co-induction of *RNR2-RNR4* plus *RNR3* or *RNR1* conferred higher resistance to HU, indicating that co-expression of large and small RNR subunits is highly important for the viability of *rad53* mutant cells under the assayed conditions. These results are not just due to co-expression of a certain number of RNR subunits, irrespective of which of them are induced, as overexpression of *RNR1-3-2* or *RNR1-3-4* did not increase the resistance to HU of *rad53*Δ cells ([Supplementary Fig. S2d](#s1){ref-type="supplementary-material"}). Furthermore, a *rad53*Δ strain carrying three inducible *RNR1* copies placed at different positions in the genome (*rad53*Δ*GAL-RNR1-1-1*) was as sensitive to HU as a *rad53*Δ strain ([Supplementary Fig. S2e](#s1){ref-type="supplementary-material"}). Therefore, we conclude that the regulation of specific-RNR subunits is critical for the viability of *rad53*Δ mutants exposed to HU.

As shown above, although *EXO1* deletion was completely ineffective in suppressing the sensitivity of *rad53* mutants to HU[@b11], it made some contribution to fork restart after a HU block ([Fig. 1c](#f1){ref-type="fig"}). Therefore, we next asked whether *EXO1* deletion could contribute to the viability of *rad53*-deficient cells with induced RNR expression after HU treatment. As shown in [Figure 2d](#f2){ref-type="fig"}, deletion of *EXO1* increased the resistance to HU of the *rad53*Δ*GAL-RNR2-4, rad53*Δ*GAL-RNR3-2-4* and *rad53*Δ*GAL-RNR1-2-4* mutants when they are grown in the presence of galactose. These results strongly argue that both Exo1-prevention and RNR-induction mechanisms are important for the viability of *rad53* mutants in the presence of HU-induced replicative stress.

In addition to regulating transcription, Rad53 also promotes removal of two negative regulators of RNR, Sml1 and Dif1. We routinely delete *SML1* to suppress the lethality of *RAD53* deletion. We next asked whether deletion of *DIF1*, which facilitates the localization of Rnr2-4 to the cytoplasm, would contribute to cell survival in the presence of HU. [Figure 2e](#f2){ref-type="fig"} shows that the *rad53*Δ*GAL-RNR3-2-4exo1*Δ*dif1*Δ mutant is indeed more resistant to HU than the *rad53*Δ*GAL-3-2-4exo1*Δ mutant, arguing that Rad53-dependent regulation of RNR cellular localization through Dif1 contributes to cell survival in the presence of HU.

RNR expression promotes replication resumption after fork stalling in *rad53* mutants in the absence of *EXO1*
--------------------------------------------------------------------------------------------------------------

As the resistance to HU is expected to correlate with the ability of cells to resume and complete chromosome replication after the replicative stress induced by this drug, we next examined whether RNR expression and *EXO1* deletion contribute to replication restart in *rad53*Δ mutant cells after HU arrest. The simple growth assay in the previous experiments cannot distinguish between gene expression requirements during or after HU treatment, because cells are exposed to HU chronically. We therefore used the GAL-inducible system to analyse replication resumption when *RNR* genes are expressed exclusively after HU removal during a single S-phase ([Fig. 3](#f3){ref-type="fig"}).

We analysed replication resumption by measuring DNA content by flow cytometry in *rad53*Δ*EXO1*^+^ or *rad53*Δ*exo1*Δ strains overexpressing *RNR1*, *RNR3-2-4* or *RNR1-2-4* ([Fig. 3a, b, c](#f3){ref-type="fig"}). Cells were grown in raffinose (RAF)-containing medium, synchronized in G1 phase with α-factor and released into fresh medium supplemented with 0.2 M HU. After 3 h, the cells were released from the HU arrest into fresh medium containing either glucose (repressive, *GAL1,10* promoter OFF) or galactose (activating, *GAL1,10* promoter ON). [Figure 3a](#f3){ref-type="fig"} shows that whereas *RAD53^+^* cells completed replication after HU-release, *rad53*Δ cells did not reach the 2C DNA content peak when *RNR1* was induced, regardless of the presence or the absence of Exo1, indicating that these cells could not finish S-phase. By contrast, although induction of *RNR3-2-4* did not allow by itself the completion of S-phase ([Fig. 3b](#f3){ref-type="fig"}, left), it led to efficient replication resumption when it was combined with *EXO1* deletion, allowing cells to reach a 2C DNA content by 180 min after HU removal ([Fig. 3b](#f3){ref-type="fig"}, right). Similar results were obtained when *EXO1* was deleted in *rad53*Δ*GAL-RNR1-2-4* or *rad53*Δ*GAL-RNR2-4* strains ([Fig. 3c](#f3){ref-type="fig"}, [Supplementary Fig. S3](#s1){ref-type="supplementary-material"}). Consistent with these data, a significant percentage of *rad53*Δ*exo1*Δ cells (35%) survived after an acute HU-treatment when *RNR3-2-4* genes were expressed after HU-removal ([Fig. 3d](#f3){ref-type="fig"}). This is a notable increase in cell viability, taking into account that RNR overexpression severely affects growth of the *rad53*Δ*RNR3-2-4* strain ([Fig. 2c](#f2){ref-type="fig"}). Importantly, the viability remained low when cells were plated immediately after HU-treatment, and it only recovered when cells were plated 2 h after HU-release in the presence of galactose ([Fig. 3d](#f3){ref-type="fig"}). All these results indicate that both the expression of *RNR* genes and the deletion of *EXO1* are necessary for the resumption of DNA synthesis after HU arrest in *rad53*Δ cells.

As shown in [Fig. 2e](#f2){ref-type="fig"}, deleting *DIF1* contributes to increase HU-resistance in the *rad53*Δ*exo1*Δ*GAL-RNR3-2-4* strain. Therefore we tested whether the absence of Dif1 could also contribute to replication resumption after release from a HU-block. [Figure 3e](#f3){ref-type="fig"} shows that *rad53*Δ*exo1*Δ*GAL-RNR3-2-4* cells appeared to complete replication earlier in the absence of Dif1, and thus the *rad53*Δ*exo1*Δ*GAL-RNR3-2-4 dif1*Δ mutant strain showed a 2C DNA content 2 h after release from HU arrest in medium with galactose. This result indicates that Dif1 inhibition, and therefore the correct RNR subcellular localization, is also important for replication resumption after fork stalling.

Taken together, these experiments show that Rad53-dependent regulation of the expression and subcellular localization of RNR, in conjunction with Rad53-dependent inhibition of Exo1, are critical for the resumption of replication after HU arrest.

RNR expression restores replication fork restart in *rad53*Δ*exo1*Δ cells after replicative stress
--------------------------------------------------------------------------------------------------

Flow cytometry analysis indicated that *rad53*Δ*exo1*Δ mutants were able to resume replication and reached a 2C DNA content when *RNR2-4,* *RNR3-2-4* or *RNR1-2-4* were expressed after fork stalling induced by HU ([Fig. 3](#f3){ref-type="fig"}). However, replication resumption could be due to the restart of DNA replication forks blocked during HU treatment or, instead, global replication could be rescued by new origin firing. To address this issue, we used density transfer and examined replication fork resumption within a single replicon on chromosome VI. In this experiment, we followed replication from *ARS607* (fragment 1) to positions 3, 4 and 6 located at 20 kb, 40 kb or 65 kb away respectively ([Fig. 4](#f4){ref-type="fig"}). Importantly, we used a strain that lacks *ARS608* and *ARS609* origins, and therefore, the examined replicon can only be replicated from *ARS607* and from a subtelomeric origin associated with the X-element at the end of the chromosome, which is only activated in the absence of Rad53-dependent inhibition of late origin firing[@b10][@b11].

*rad53*Δ*exo1*Δ*GAL-RNR3-2-4* cells were initially grown in the presence of heavy isotopes, synchronized in G1 with α-factor, and then released into fresh medium with light isotopes in the presence of 0.2 M HU. After 3 h in HU, these cells were released into fresh medium in the presence of glucose or galactose for 2 h. Flow cytometry ([Fig. 4a](#f4){ref-type="fig"}) shows that the cells reached a 2C DNA content when released into galactose-containing medium after release from the HU-block, in agreement with data in [Fig. 3b](#f3){ref-type="fig"}. Density transfer experiments ([Fig. 4b](#f4){ref-type="fig"}) showed that when the cells were released from the G1-block in the presence of HU, there was some replication (HL peak) in fragments 1 and 6, indicating that the *ARS607* origin fired normally and that the subtelomeric origin located at the end of the chromosome was also activated due to the absence of Rad53. As mentioned above, the severe phenotype of *rad53* mutants exposed to high concentrations of HU led to very little replication of fragments 1 and 6 ([Fig. 4b](#f4){ref-type="fig"}). When HU-release took place under conditions of *RNR* repression (GLC), fork restart was highly defective, as judged by the high amounts of unreplicated (HH) DNA that remained 2 h after HU-release in all restriction fragments. Remarkably, galactose induction of *RNR3-2-4* (GAL) after HU arrest significantly increased the amount of replication of fragments 1, 3, 4 and 6 in the *rad53*Δ*exo1*Δ background. Importantly, the extent of replication of the origin-distal fragments 3 and 4, which can only be passively replicated, increased up to 68 and 67% ([Fig. 4c](#f4){ref-type="fig"}), indicating that a high fraction of stalled-replication forks indeed recovered from the HU-block when RNR was expressed. These data indicate that replication resumption after RNR induction in a *rad53*Δ*exo1*Δ background is due to fork restart.

Discussion
==========

In order to cope with replicative stress, cells need the efficient coordination of mechanisms that protect DNA replication forks and allow replication resumption after fork stalling, so that chromosome replication can be completed and genome stability is preserved. In this work, we show that the Rad53 checkpoint kinase promotes replication fork restart after HU treatment by inducing the expression of RNR and counteracting the RNR regulator Dif1. In addition, we show that replication fork restart after exposure to HU also requires Rad53-dependent inhibition of Exo1, which, as shown before, is necessary to avoid fork breakdown[@b11][@b12]. These results expand the view of how Rad53 controls several aspects of DNA replication under conditions of replicative stress and, taken with previous data, allows proposing the following model for the action of this checkpoint protein (depicted in [Fig. 5](#f5){ref-type="fig"}): first, Rad53 inhibits the activation of additional replication origins by phosphorylating Sld3 and Dbf4[@b15][@b16]; second, Rad53 prevents Exo1 from exerting a deleterious effect on replication forks[@b11][@b12]; and third, as shown here, Rad53 promotes replication restart by inducing the synthesis and activation of RNR, which is especially important after HU treatment.

It was previously shown that *RNR1* or *RNR3* overexpression suppresses *rad53*Δ lethality but not the extreme sensitivity of this checkpoint mutant to genotoxic stress[@b38], which questioned the importance of increasing the expression of genes encoding RNR for cell survival after replicative stress. However, we show here that co-expression of specific RNR subunits increases the viability of *rad53*Δ mutants after replication blocks. In addition, we show that *EXO1* deletion clearly contributes to the survival of *rad53*Δ cells in the presence of HU when RNR expression is induced, arguing that Exo1-regulation has a previously unnoticed role in the survival of *rad53* mutants after replicative stress. Therefore, two Rad53 functions, preservation of fork integrity and up-regulation of RNR, are important for cell survival upon HU-induced replicative stress. Furthermore, we show that these two functions are necessary to promote fork restart after replication blockage. This essential role in fork restart explains why these Rad53 activities are required for cell viability and uncovers how the Rad53 checkpoint protein facilitates replication resumption from stalled forks.

It is currently unclear why new synthesis of RNR subunits after HU treatment is important for fork restart. One possibility is that the RNR-complex becomes irreversibly inactivated after prolonged HU treatment. In this respect, it is known that HU blocks DNA synthesis by reducing the RNR free radical contained in the small subunit[@b44], and our results indicate that new expression of Rnr2-Rnr4 is essential for cell survival after replicative stress in the absence of Rad53. The fact that additional co-expression of *RNR3* or *RNR1* further increased the recovery after HU treatment could suggest that the expression of small and large RNR-subunits is required to form an enzymatically active complex that is able to supply appropriate dNTP levels. A second possibility to explain the requirement of RNR expression for replication resumption after fork stalling is that the increased dNTP concentration associated with the DNA damage response[@b45] may be critical for some aspect of DNA polymerase function in fork restart.

Strikingly, while our results indicate that fork recovery in *rad53* mutants is largely dependent on the new synthesis of RNR, it is known that new protein synthesis is dispensable for replication resumption after HU arrest in wild-type cells[@b8][@b19]. A possible explanation for these data is that Rad53-dependent RNR regulation might involve an active mechanism to re-activate RNR after HU treatment. In this scenario, wild-type cells would not be able to synthesize RNR in the absence of new protein synthesis, but would be capable of re-activating the remaining RNR pool. This could be also an explanation for the low rate of DNA synthesis after replication blocks that is observed when new protein synthesis is inhibited[@b8]. By contrast, all of these RNR-regulatory mechanisms would be impaired in *rad53* cells, thus explaining why new RNR synthesis is strictly required for fork resumption in this checkpoint mutant.

Cells have evolved several strategies to regulate RNR activity, such as control of gene expression, inhibitor destruction, and subcellular localization[@b20][@b30][@b31]. Additionally, protein-protein interactions between RNR and several cell cycle regulators could also modulate RNR activity[@b35][@b46]. Interestingly, a novel mechanism for the regulation of the activity of the mammalian RNR-subunit p53R2 via ATM-mediated phosphorylation has been reported[@b47]. Future examination of the possible interactions between the RNR-complex and the checkpoint machinery is required to explore this potential level of regulation in budding yeast.

DNA damage checkpoints act as a barrier to the development of cancer[@b48][@b49] and, therefore, down-regulation of checkpoints may contribute to carcinogenesis. Besides, intense cell proliferation requires high rates of DNA synthesis, and an elevated RNR activity has been associated with tumorogenesis[@b50][@b51]. Checkpoint-defective cancer cells may be especially sensitive to the chemotherapies that damage DNA, deplete nucleotide pools or otherwise interfere with replication fork progression. The loss of checkpoint targets like Exo1 and Dif1 may contribute to emerging drug resistance of such cancer cells.

Methods
=======

Strains, Plasmids and Growth Conditions
---------------------------------------

All the yeast strains are derived from W303-1a and constructed by standard techniques. They are described in [Supplementary Table S1](#s1){ref-type="supplementary-material"}. The ORFs encoding the different RNR subunits were amplified by PCR and cloned into pRS-GAL1,10 vectors. The resulting *GAL1,10-RNR* cassettes were integrated in the genome of a *sml1*Δ strain at the positions indicated in [Supplementary Table S1](#s1){ref-type="supplementary-material"}. The resulting strains were then crossed with *rad53*Δ or *rad53*Δ*exo1*Δ strains of the opposite mating type to generate diploids that were tetrad dissected after sporulation to obtain the strains used in the study.

Strains were grown regularly in YP medium plus glucose (2%) (YPD) at 30°C. For the induction experiments using the *GAL1,10* promoter, raffinose (2%) was used to facilitate the induction of the relevant gene upon addition of galactose (2%). Cells were synchronized in G1 phase with the mating pheromone α-factor at 10 μg/ml. In cell cycle experiments, hydroxyurea (HU) was used at 0.2 M. In raffinose-medium, cell cycle progression is slower, and thereby, cells were held in HU for 3 h to ensure S-phase onset.

Drop assays
-----------

Cultures growing exponentially were normalised and 1:5 serial dilutions were spotted onto YPD, YPGAL, YPD + HU or YPGAL + HU plates, depending on the experiment.

DNA replication analysis assays
-------------------------------

Samples for flow-cytometry analysis were fixed with 70% ethanol and processed as described[@b52]. Density transfer assays were performed and analysed essentially as described[@b53]. All the strains used for these experiments lack the *ARS608* and *ARS609*[@b11]. DNA was digested with *Cla*I and *Sal*I before gradient centrifugation in CsCl. Probes corresponding to the analysed fragments were as described[@b11]. The extent of replication was calculated as: % replication = 100\[0.5 HL/(HH + 0.5 HL)\].

Protein electrophoresis and immunoblotting
------------------------------------------

Protein extracts were prepared as described previously[@b54]. For western blot analysis, proteins were separated by SDS-page and transferred to a nitrocellulose membrane (GE-healthcare). Membranes were cut in two halves, and the upper or lower parts were used to detect RNR or PGK respectively. Detection of Rnr1 was performed using the rabbit polyclonal antibody AS09 576 (Agrisera; dilution 1:5000); Rnr3 was detected using the rabbit polyclonal antibody AS09 574 (Agrisera; dilution 1:1000); PGK was detected using the mouse polyclonal antibody A-6457 (Sigma; dilution 1:10000); Horseradish-peroxidase-coupled anti-rabbit or anti-mouse were used as the secondary antibodies. Immunoreactive bands were visualized by enhanced chemiluminescence (ECL, GE Healthcare) according to the manufacturer\'s instructions. Protein electrophoresis was carried out using 7.5% and 12% SDS-PAGE gels. The proteins were stained with Coomassie Blue after the electrophoresis.
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![*EXO1* affects replication fork restart in *rad53*Δ cells after HU arrest.\
(a) Drop assays on YPD plus the indicated concentrations of HU were performed using 1:5 serial dilutions of exponentially growing cultures of *RAD53^+^EXO1^+^*, *rad53*Δ*EXO1^+^* or *rad53*Δ*exo1*Δ strains. *SML1* was previously deleted in all of them to allow viability in the absence of *RAD53*. (b) The strains were synchronized in G1 with α−factor and released into YPD medium containing 0.2 M HU for 2 h. HU was then removed and cells were released into fresh YPD medium for 2 h. Samples were taken every 30 min, and DNA content was measured by flow cytometry. (c) Replication fork progression was followed by density transfer, as described in the text. Cells were blocked in G1 with α-factor and released into medium containing HU for 90 min. HU was then removed and cultures were released into HU-free medium for 120 min. DNA content at the indicated time points is shown in [Supplementary Fig. S1a](#s1){ref-type="supplementary-material"}. The sizes and positions of the restriction fragments 1 and 3 of the analysed replicon on chromosome VI are represented in the scheme. The relative amounts of radioactivity in the hybridized DNA are plotted against the gradient fraction number. The position of unreplicated (HH) and replicated (HL) DNA peaks is indicated at the top. Black arrows indicated fork movement from *ARS607*. The position of the initial HH peak is shown as a reference (gray area). (d) The graph shows the percentage of replicated DNA at positions *ARS607* and fragment 3 in the *RAD53^+^* strain (white bars), *rad53*Δ strain (gray bars) and *rad53*Δ*exo1*Δ strain (black bars) at the end of the experiment shown in Figure 1C.](srep07886-f1){#f1}

![*EXO1* deletion and checkpoint-dependent RNR expression contribute to cell viability in the presence of replicative stress.\
(a) 1:5 serial dilutions of exponential cultures of the indicated strains were tested for sensitivity to 10 mM HU, by using a drop assay on YPD plates (top) or YPGAL plates (bottom). (b) The indicated strains were tested for sensitivity to 10 mM and 20 mM HU as described in (a). (c) Drop assays on YPD or YPGal were performed with the indicated strains as described in (a). (d) Sensitivity to 10 mM, 15 mM or 20 mM HU was analyzed as described in (a). (e) Drop assays of the indicated strains as in (b).](srep07886-f2){#f2}

![RNR expression allows replication resumption in *rad53*Δ*exo1*Δ mutants after fork stalling.\
(a) Cultures of *RAD53^+^, rad53*Δ*GAL-RNR1* and *rad53*Δ*exo1*Δ*GAL-RNR1* strains were grown in YPRAF medium, arrested in G1 with α-factor, and released from the G1 block into RAF-containing medium containing 0.2 M HU. After 3 h in HU, cultures were released into fresh medium in the presence of Glc (left panel) or Gal (right panel). DNA content was measured by flow cytometry at the indicated times. The expression of Rnr1 was followed by immunoblot analysis (bottom panel) as described in Methods. A Ponceau-S-stained membrane coincident with Rnr1 migration was used as a loading control. Full-length blots are presented in [Supplementary figure S4](#s1){ref-type="supplementary-material"}. (b) Analysis of S phase progression of *rad53*Δ*EXO1^+^GAL-RNR3-2-4* and *rad53*Δ*exo1*Δ*GAL-RNR3-2-4* strains as described in (a). The expression of Rnr3 was followed by immunoblot analysis (bottom panel) as described in (a). (c) Analysis of S phase progression of *rad53*Δ*EXO1^+^GAL-RNR1-2-4* and *rad53*Δ*exo1*Δ*GAL-RNR1-2-4* strains as described in (a). (d) *rad53*Δ*exo1*Δ*GAL-RNR3-2-4* cells were grown in YPRAF medium and arrested in G1 with α-factor. The culture was divided in two and incubated in either YPD (white column) or YPRAF (black column) in the presence of 0.2 M HU for 3 h. The YPD-culture was then released from HU into fresh medium with Glc, while the YPRAF-culture was released in the presence of Gal. Cells were tested for viability after α−factor arrest, after 3 h in the presence of 0.2 M HU, and 2 h after release from HU. (e) Analysis of S phase progression of *rad53*Δ*EXO1^+^dif1*Δ*GAL-RNR3-2-4* and *rad53*Δ*exo1*Δ*dif1*Δ*GAL-RNR3-2-4* strains as described in (a).](srep07886-f3){#f3}

![New DNA synthesis in *rad53*Δ*exo1*Δ*GAL-RNR2-3-4* mutants after replication blocks is due to fork restart.\
(a) The experiment was performed as in [Fig. 3a](#f3){ref-type="fig"}, with slight modifications described in (b). DNA content of *rad53*Δ*exo1*Δ*GAL-RNR2-3-4* cells was determined by flow cytometry at the indicated time points. (b) Replication fork progression was analysed in the *rad53*Δ*exo1*Δ*GAL-RNR2-3-4* strain by density transfer. Cells were initially grown in 0.1% Glc in medium with heavy isotopes, and then blocked in G1 with α−factor. After G1 arrest, cells were released into medium containing HU and light isotopes, under conditions that prevented *GAL1,10*-dependent expression. Cells were held in HU for 3 h and then released from the HU arrest into fresh medium with either Glc or Gal. The position of the four *Cla*I/*Sal*I restriction fragments from chromosome VI that were analysed is shown at the top, coincident with *ARS607* and 20, 40, and 65 kb away from the origin. (c) Percentage of replicated DNA in the *rad53*Δ*exo1*Δ*GAL-RNR2-3-4* strain after HU-release in the presence of GLC or GAL (from [Fig. 3b](#f3){ref-type="fig"}). The amount of replicated DNA at each fragment was plotted against distance from the *ARS607* sequence. White bars represent RNR-repressing conditions (GLC) and black bars RNR-expressing conditions (GAL).](srep07886-f4){#f4}

![Model for regulation of DNA replication by Rad53.\
This model summarizes the different processes of DNA replication in which Rad53 regulation is involved. The replication forks activate the sensor kinase Mec1, which then phosphorylates the downstream kinase Rad53. Rad53 works through phosphorylation of Sld3 and Dbf4 to inhibit late origin firing. Rad53 works through inhibition of Exo1 to stabilize replication forks and through Ixr1 and Dun1-dependent induction and activation of RNR to promote fork restart.](srep07886-f5){#f5}
